{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-136674","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2024-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.748862+00:00","generated_at":"2026-05-29T02:53:42.884978+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Akari Therapeutics appoints Torsten Hombeck as CFO effective Dec 16, 2024","bullets":["Torsten Hombeck appointed CFO effective Dec 16, 2024; previously served as CFO from Oct 2019 to June 2024.","Annual base salary of $300,000 with target bonus of up to 100%.","Dr. Hombeck most recently served as CFO at Aspira Women's Health (June 2023–June 2024).","No family relationships or transactions with other directors or officers noted."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-136674","json":"https://secwatch.observer/filing/0000950170-24-136674.json","markdown":"https://secwatch.observer/filing/0000950170-24-136674.md","text":"https://secwatch.observer/filing/0000950170-24-136674.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000095017024136674/0000950170-24-136674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000095017024136674/aktx-20241212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:53:42.884978+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}